Zeitschriftenartikel zum Thema „Leukemia Chemotherapy“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Leukemia Chemotherapy" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Narayanan, Geetha, M. T. Sugeeth und Lali V. Soman. „Mixed Phenotype Acute Leukemia Presenting as Leukemia Cutis“. Case Reports in Medicine 2016 (2016): 1–3. http://dx.doi.org/10.1155/2016/1298375.
Dias, Sergio, Margaret Choy, Kari Alitalo und Shahin Rafii. „Vascular endothelial growth factor (VEGF)–C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy“. Blood 99, Nr. 6 (15.03.2002): 2179–84. http://dx.doi.org/10.1182/blood.v99.6.2179.
Wu, K. H., H. P. Wu, H. J. Lin, C. H. Wang, H. Y. Chen, T. Weng, C. T. Peng und Y. H. Chao. „Concurrent hypopituitarism and leukemic retinopathy in a child with B-precursor acute lymphoblastic leukemia and isolated central nervous system relapse“. Current Oncology 23, Nr. 4 (08.08.2016): 431. http://dx.doi.org/10.3747/co.23.3006.
Falqués, Ton, Mattias Pilheden, Qirui Zhang, Louise Ahlgren, Helena Sturesson, Lars Ronnstrand, Axel Hyrenius Wittsten, Julhash U. Kazi und Anna Hagstroem-Andersson. „Treatment Shapes Clonal Evolution and Resistance Patterns in Murine KMT2A-Rearranged Leukemia with Subclonal FLT3 N676K“. Blood 138, Supplement 1 (05.11.2021): 3354. http://dx.doi.org/10.1182/blood-2021-144760.
Moha, Rico. „Chemotherapy medication of Vincristine and Vinblastine“. Cancer Research and Cellular Therapeutics 1, Nr. 1 (08.12.2017): 01–02. http://dx.doi.org/10.31579/2640-1053/007.
Becker, Pamela S. „Dependence of Acute Myeloid Leukemia on Adhesion within the Bone Marrow Microenvironment“. Scientific World Journal 2012 (2012): 1–4. http://dx.doi.org/10.1100/2012/856467.
Frankfurt, Olga, und Martin S. Tallman. „Growth Factors in Leukemia“. Journal of the National Comprehensive Cancer Network 5, Nr. 2 (Februar 2007): 203–15. http://dx.doi.org/10.6004/jnccn.2007.0020.
DeAngelo, Daniel J., Eytan M. Stein und Farhad Ravandi. „Evolving Therapies in Acute Myeloid Leukemia: Progress at Last?“ American Society of Clinical Oncology Educational Book, Nr. 36 (Mai 2016): e302-e312. http://dx.doi.org/10.1200/edbk_161258.
Kumar, Bijender, Marvin Orellana, Jamison Brooks, Srideshikan Sargur Madabushi, Liliana E Parra, Darren Zuro, Qiong Wang, Ching-Cheng Chen und Susanta Hui. „Leukemia Cells Remodel Adipocyte Niches and Their Progenitor Functions to Generate Leukemia Favoring Niche“. Blood 132, Supplement 1 (29.11.2018): 1294. http://dx.doi.org/10.1182/blood-2018-99-115689.
Hapsari, Happy Indri. „INCREASING KNOWLEDGE OF PARENTS IN CARE OF THE SIDE EFFECTS OF CHEMOTHERAPY IN LEUKEMIA CHILDREN THROUGH BOOKLET IN DR. MOEWARDI GENERAL HOSPITAL SURAKARTA“. Jurnal Ilmiah Kesehatan Media Husada 8, Nr. 2 (24.10.2019): 39–47. http://dx.doi.org/10.33475/jikmh.v8i2.196.
Kampa-Schittenhelm, Kerstin M., Charles D. Lopez und Marcus Schittenhelm. „ASPP2 Expression In Acute Leukemia Modulates Response to Therapy“. Blood 116, Nr. 21 (19.11.2010): 3143. http://dx.doi.org/10.1182/blood.v116.21.3143.3143.
Ptasiewicz, Maja, Paweł Maksymiuk und Renata Chałas. „Changes of Dentition State in Leukemic Patients during Chemotherapy“. International Journal of Environmental Research and Public Health 18, Nr. 15 (02.08.2021): 8193. http://dx.doi.org/10.3390/ijerph18158193.
Swatler, Julian, Laura Turos-Korgul, Ewa Kozlowska und Katarzyna Piwocka. „Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias“. Cancers 13, Nr. 6 (10.03.2021): 1203. http://dx.doi.org/10.3390/cancers13061203.
Swatler, Julian, Laura Turos-Korgul, Marta Brewinska-Olchowik, Sara De Biasi, Wioleta Dudka, Bac Viet Le, Agata Kominek et al. „4-1BBL–containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells“. Blood Advances 6, Nr. 6 (17.03.2022): 1879–94. http://dx.doi.org/10.1182/bloodadvances.2021006195.
Buss, Eike C., Alexander Kalinkovich, Amir Schajnovitz, Orit Kollet, Ayelet Dar, Melania Tesio, Stefan Fruehauf et al. „In Vivo Mobilization of Leukemic Human Precursor-B-ALL Cells by the CXCR4-Antagonist AMD3100 Is Via Secretion of SDF-1 and Synergistically by Catecholamine Action.“ Blood 112, Nr. 11 (16.11.2008): 1920. http://dx.doi.org/10.1182/blood.v112.11.1920.1920.
Lam, Wilbur A., Michael J. Rosenbluth und Daniel A. Fletcher. „Chemotherapy Exposure Decreases Leukemia Cell Deformability as Determined by Atomic Force Microscopy: Implications for Leukostasis in Acute Leukemia.“ Blood 108, Nr. 11 (01.11.2006): 2359. http://dx.doi.org/10.1182/blood.v108.11.2359.2359.
Subramaniam, Priya, K. Girish Babu und J. Nagarathna. „Oral Manifestations In Acute Lymphoblastic Leukemic Children Under Chemotherapy“. Journal of Clinical Pediatric Dentistry 32, Nr. 4 (01.07.2008): 319–24. http://dx.doi.org/10.17796/jcpd.32.4.0p1462t621w20477.
Dunussi-Joannopoulos, Kyriaki, Werner Krenger, Howard J. Weinstein, James L. M. Ferrara und James M. Croop. „CD8+ T Cells Activated During the Course of Murine Acute Myelogenous Leukemia Elicit Therapeutic Responses to Late B7 Vaccines After Cytoreductive Treatment“. Blood 89, Nr. 8 (15.04.1997): 2915–24. http://dx.doi.org/10.1182/blood.v89.8.2915.
Diamandidou, E., A. U. Buzdar, T. L. Smith, D. Frye, M. Witjaksono und G. N. Hortobagyi. „Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.“ Journal of Clinical Oncology 14, Nr. 10 (Oktober 1996): 2722–30. http://dx.doi.org/10.1200/jco.1996.14.10.2722.
Sohn, CC, DW Blayney, JL Misset, G. Mathe, G. Flandrin, EM Moran, FC Jensen, CD Winberg und H. Rappaport. „Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retroviruses“. Blood 67, Nr. 4 (01.04.1986): 949–56. http://dx.doi.org/10.1182/blood.v67.4.949.949.
Sohn, CC, DW Blayney, JL Misset, G. Mathe, G. Flandrin, EM Moran, FC Jensen, CD Winberg und H. Rappaport. „Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retroviruses“. Blood 67, Nr. 4 (01.04.1986): 949–56. http://dx.doi.org/10.1182/blood.v67.4.949.bloodjournal674949.
Zeng, Zhihong, Yue Xi Shi, Ismael J. Samudio, Rui-Yu Wang, Xiaoyang Ling, Olga Frolova, Mark Levis et al. „Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML“. Blood 113, Nr. 24 (11.06.2009): 6215–24. http://dx.doi.org/10.1182/blood-2008-05-158311.
YORIMITSU, Seiichi. „Induction Chemotherapy for Acute Leukemia“. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 97, Nr. 3-4 (1985): 277–87. http://dx.doi.org/10.4044/joma1947.97.3-4_277.
YORIMITSU, Seiichi. „Induction Chemotherapy for Acute Leukemia“. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 97, Nr. 3-4 (1985): 289–99. http://dx.doi.org/10.4044/joma1947.97.3-4_289.
HARA, Masamichi. „Induction chemotherapy for acute leukemia“. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 98, Nr. 3-4 (1986): 243–54. http://dx.doi.org/10.4044/joma1947.98.3-4_243.
HARA, Masamichi. „Induction chemotherapy for acute leukemia“. Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 98, Nr. 3-4 (1986): 255–64. http://dx.doi.org/10.4044/joma1947.98.3-4_255.
ONO, RYUZO. „Blood. Chemotherapy of the leukemia.“ Nihon Naika Gakkai Zasshi 86, Nr. 3 (1997): 477–80. http://dx.doi.org/10.2169/naika.86.477.
Pieters, Rob, Annemiek M. Schans-Dop, A. Ine Brenk, Annette HM Taets Amerongen und Anjo JP Veerman. „OSTEONECROSIS FOLLOWING CHEMOTHERAPY FOR LEUKEMIA“. European Journal of Haematology 43, Nr. 3 (24.04.2009): 262–64. http://dx.doi.org/10.1111/j.1600-0609.1989.tb00295.x.
Chasen, Martin R., und Geoffrey Falkson. „Leukemia after Chemotherapy for Cancer“. Cancer Biotherapy 8, Nr. 2 (Januar 1993): 115–22. http://dx.doi.org/10.1089/cbr.1993.8.115.
Adra, Nabil, Hamid Sayar und Lawrence H. Einhorn. „Chemotherapy-Related Chronic Myelogenous Leukemia“. JAMA Oncology 2, Nr. 3 (01.03.2016): 391. http://dx.doi.org/10.1001/jamaoncol.2015.4837.
Lu, Hongbo, Zhihong Zeng, Yuexi Shi, Sergej Konoplev, Donald Wong, Marina Konopleva und Michael Andreeff. „Disruption of Leukemia/Stroma Cell Interactions by CXCR4 Antagonist CTCE-9908 Enhances Chemotherapy-Induced Apoptosis in AML“. Blood 112, Nr. 11 (16.11.2008): 2415. http://dx.doi.org/10.1182/blood.v112.11.2415.2415.
Barve, Vega, Shah, Ghare, Casson, Wunderlich, Siskind und Beverly. „Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia“. Cells 8, Nr. 11 (25.10.2019): 1322. http://dx.doi.org/10.3390/cells8111322.
Ratain, MJ, LS Kaminer, JD Bitran, RA Larson, MM Le Beau, C. Skosey, S. Purl, PC Hoffman, J. Wade und JW Vardiman. „Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung“. Blood 70, Nr. 5 (01.11.1987): 1412–17. http://dx.doi.org/10.1182/blood.v70.5.1412.1412.
Ratain, MJ, LS Kaminer, JD Bitran, RA Larson, MM Le Beau, C. Skosey, S. Purl, PC Hoffman, J. Wade und JW Vardiman. „Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung“. Blood 70, Nr. 5 (01.11.1987): 1412–17. http://dx.doi.org/10.1182/blood.v70.5.1412.bloodjournal7051412.
Ueda, Yutaka. „Problems in anti-leukemic drugs chemotherapy of childhood acute leukemia.“ Journal of Nippon Medical School 54, Nr. 6 (1987): 573–80. http://dx.doi.org/10.1272/jnms1923.54.573.
Cavanna, Luigi, Daniele Vallisa, Michele Di Stasi, Fabio Fornari, Elisabetta Buscarini, Claudio Schena, Giuseppe Civardi, Giorgio Sbolli, Raffaella Berte und Luigi Buscarini. „Acute Myelocytic Leukemia and Chronic Myelomonocytic Leukemia Simultaneously with Resectable Breast Cancer: A Report of two Cases“. Tumori Journal 78, Nr. 5 (Oktober 1992): 356–58. http://dx.doi.org/10.1177/030089169207800516.
Milojkovic, Dragana, und Jane F. Apperley. „How I treat leukemia during pregnancy“. Blood 123, Nr. 7 (13.02.2014): 974–84. http://dx.doi.org/10.1182/blood-2013-08-283580.
Shi, Yang, und Endi Wang. „Blastic Plasmacytoid Dendritic Cell Neoplasm: A Clinicopathologic Review“. Archives of Pathology & Laboratory Medicine 138, Nr. 4 (01.04.2014): 564–69. http://dx.doi.org/10.5858/arpa.2013-0101-rs.
Yeasmin, S., K. Nakayama, M. Ishibashi, A. Oride, A. Katagiri, I. N. Purwana, K. Iida, N. Nakayama, H. Ishikura und K. Miyazaki. „Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review“. International Journal of Gynecologic Cancer 18, Nr. 6 (2008): 1371–76. http://dx.doi.org/10.1111/j.1525-1438.2007.01185.x.
Freireich, Emil J. „Prevention of chemotherapy-induced leukemia and of leukemia relapses“. Medical Oncology and Tumor Pharmacotherapy 8, Nr. 3 (September 1991): 155–58. http://dx.doi.org/10.1007/bf02987173.
Eshghabadi, M., A. M. Shojania und I. Carr. „Isolated granulocytic sarcoma: report of a case and review of the literature.“ Journal of Clinical Oncology 4, Nr. 6 (Juni 1986): 912–17. http://dx.doi.org/10.1200/jco.1986.4.6.912.
Zhang, Ziting, Kun Yang und Han Zhang. „Targeting Leukemia-Initiating Cells and Leukemic Niches: The Next Therapy Station for T-Cell Acute Lymphoblastic Leukemia?“ Cancers 14, Nr. 22 (17.11.2022): 5655. http://dx.doi.org/10.3390/cancers14225655.
Chistyakova, Natalia V. „Ophthalmic manifestation of leukemia“. Ophthalmology journal 9, Nr. 2 (15.06.2016): 81–99. http://dx.doi.org/10.17816/ov9281-99.
Jabbour, Elias, Susan O’Brien, Farhad Ravandi und Hagop Kantarjian. „Monoclonal antibodies in acute lymphoblastic leukemia“. Blood 125, Nr. 26 (25.06.2015): 4010–16. http://dx.doi.org/10.1182/blood-2014-08-596403.
V.E., Mayorova,, Mollaev, M.D., Vikhreva, P.N., Kulakovskaya, E.A., Pershin, D.E., Kibardin, A.V., Maschan, M.A. und Larin, S.S. „ANTIBODY-FREE CHIMERIC FLT3-CAR RECEPTOR FOR TARGETING THE FLT3 RECEPTOR, A MARKER OF POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA“. CARDIOMETRY, Nr. 24 (30.11.2022): 63–65. http://dx.doi.org/10.18137/cardiometry.2022.24.conf.35.
Journal, Baghdad Science. „Evaluation of ELectrolytes in Adult Patients with Acute Leukemia before and after Chemotherapy“. Baghdad Science Journal 10, Nr. 2 (02.06.2013): 362–67. http://dx.doi.org/10.21123/bsj.10.2.362-367.
Shahjahani, Mohammad, Amirreza Abroun, Najmaldin Saki, Seyed Mohammad Bagher Mohammadi und Hadi Rezaeeyan. „STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia“. Laboratory Medicine 51, Nr. 4 (20.12.2019): 345–51. http://dx.doi.org/10.1093/labmed/lmz074.
Lotem, J., und L. Sachs. „Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells“. Blood 80, Nr. 7 (01.10.1992): 1750–57. http://dx.doi.org/10.1182/blood.v80.7.1750.1750.
Lotem, J., und L. Sachs. „Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells“. Blood 80, Nr. 7 (01.10.1992): 1750–57. http://dx.doi.org/10.1182/blood.v80.7.1750.bloodjournal8071750.
Coustan-Smith, Elaine, Jose Sancho, Frederick G. Behm, Michael L. Hancock, Bassem I. Razzouk, Raul C. Ribeiro, Gaston K. Rivera et al. „Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia“. Blood 100, Nr. 1 (01.07.2002): 52–58. http://dx.doi.org/10.1182/blood-2002-01-0006.